
Welldoc is a digital health platform that provides AI-driven solutions for chronic disease management, focusing on conditions such as diabetes, hypertension, and heart failure. Their flagship product, Blue Star, is an FDA-cleared medical device that empowers individuals and their care teams with personalized insights to improve health outcomes. With a strong emphasis on evidence-based care, Welldoc integrates seamlessly into existing healthcare workflows, making it a valuable partner for health plans, systems, and employers. The company has achieved significant traction with over 400 connected devices and 11 FDA clearances, positioning itself as a leader in the digital health space.

Welldoc is a digital health platform that provides AI-driven solutions for chronic disease management, focusing on conditions such as diabetes, hypertension, and heart failure. Their flagship product, Blue Star, is an FDA-cleared medical device that empowers individuals and their care teams with personalized insights to improve health outcomes. With a strong emphasis on evidence-based care, Welldoc integrates seamlessly into existing healthcare workflows, making it a valuable partner for health plans, systems, and employers. The company has achieved significant traction with over 400 connected devices and 11 FDA clearances, positioning itself as a leader in the digital health space.
Founded: 2005
Headquarters: Columbia, Maryland
Focus: AI-driven digital health for cardiometabolic conditions (diabetes, hypertension, heart failure)
Flagship product: BlueStar (FDA-cleared diabetes-focused medical device)
Funding (reported): Series B (most recent round: Mar 1, 2016); total funding reported ~$55.15M
Chronic disease management for cardiometabolic conditions (diabetes, prediabetes, hypertension, heart failure, weight management).
2005
Digital health / Healthtech
Crunchbase lists Series B as most recent round on this date.
“Johnson & Johnson Robotics and Digital Solutions; Samsung Ventures cited as lead investors in later rounds; Crunchbase lists multiple investors”